I continue to work on my issue. I have until the end of April, which is when the medications run out. I have received no fewer than 50 emails on the subject, and they are therefore too numerous to answer individually because of my work schedule. I thank each and every one of you who have emailed, messaged, and posted comments.
There has been a major breakthrough, and it appears as though I have solved the problem by getting rid of the insurance company that caused the problem in the first place. I will know more in the next few days. More to follow.
8 Comments
TCK · February 11, 2025 at 5:45 pm
Good luck, we’re all hoping this get resolved quickly and in your favor.
Lori G · February 11, 2025 at 6:03 pm
I feel terrible that someone like you who has helped so many people is now hung out to dry. This should never happen.
Borepatch · February 11, 2025 at 6:09 pm
Hey, I’ve been trying to get in touch. Can you email me? borepatch at gmail
Boneman · February 12, 2025 at 6:04 am
“Nuke ’em from orbit. It’s the only way to be sure…”
Glad to here there’s a clear path to resolution. BRAVO.
Divemedic · February 12, 2025 at 7:19 am
I currently have two- the one I prefer, and a backup in the event that one doesn’t work.
Will · February 12, 2025 at 7:33 am
I am also having insurance problems. I have a United Healthcare Medicare Advantage who recently dropped my Urologist and now I have learned they have dropped my Vision group from their network. My copay went from $35 to $75 with no warning. If you have any insight as to why an insurance company would drop a medical group, please share.
Divemedic · February 12, 2025 at 7:48 am
What you are seeing is that they dropped the provider’s tier level, perhaps from tier 1 or 2 down to a 3. That still allows you to see them, but at a higher rate. In my case, they completely removed my doctor from the payment system, which means that I can’t see them at ANY price.
Will · February 12, 2025 at 10:12 am
In the case of the Urologist, I had to pay the full office visit charge. $150. Sounds dropped.
Comments are closed.